Lily Of The Valley (Herb/Suppl)

Brand and Other Names:Convallaria majalis, Jacob's Ladder, more...May Bells, May Lily
  • Print

Suggested Dosing

Cardiac Glycosides

Insufficient reliable evidence available for effectiveness

600 mg/day PO average amount

Tincture: 6 g/day divided TID PO

Liquid extract: 600 mg/day divided TID PO

Dried extract: 150 mg/day PO

Next:

Suggested Uses

Circulatory disorders, heart palpitations, arrhythmia, CHF, cardiac edema, cardiac asthma, kidney and bladder stones, UTI

Efficacy

Contains cardiac glycosides similar to those in digitalis

Previous
Next:

Interactions

Interaction Checker

and Lily Of The Valley

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 
            Due to system maintenance, the drug interactions feature you are attempting to access is temporarily unavailable. Please try again later.
            Previous
            Next:

            Warnings

            Contraindications

            High BP, kidney/liver disease, potassium deficiency

            Pregnancy

            Cautions

            Use only under qualified supervision: potentially fatal if overdosed

            Taking more than recommended dose may cause nausea, vomiting, headache, stupor, disorders of color perception, and irregular heartbeat

            Previous
            Next:

            Pregnancy & Lactation

            Pregnancy Category: avoid

            Lactation: N/A

            Pregnancy Categories

            A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA: Information not available.

            Previous
            Next:

            Pharmacology

            Mechanism of Action

            Cardiac glycosides increase force and power of heartbeat without increasing amount of oxygen required by cardiac muscle

            Previous
            Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.